Assessment of Safety and Immunogenicity of MHC homozygous iPSC-derived CD34+ Hematopoietic Progenitors in a NHP Model

Akhilesh Kumar

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
JournalBlood Advances
StatePublished - Apr 11 2022

Cite this